Growth Metrics

Healthequity (HQY) Cash from Financing Activities (2016 - 2026)

Healthequity has reported Cash from Financing Activities over the past 14 years, most recently at -$99.8 million for Q1 2026.

  • For Q1 2026, Cash from Financing Activities fell 12.9% year-over-year to -$99.8 million; the TTM value through Jan 2026 reached -$387.0 million, down 772.22%, while the annual FY2026 figure was -$387.0 million, 772.22% down from the prior year.
  • Cash from Financing Activities for Q1 2026 was -$99.8 million at Healthequity, up from -$122.4 million in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $176.6 million in Q3 2024 and troughed at -$122.4 million in Q4 2025.
  • A 5-year average of -$22.5 million and a median of -$3.0 million in 2022 define the central range for Cash from Financing Activities.
  • On a YoY basis, Cash from Financing Activities climbed as much as 8295.68% in 2024 and fell as far as 4163.86% in 2024.
  • Year by year, Cash from Financing Activities stood at -$1.1 million in 2022, then surged by 285.21% to $2.0 million in 2023, then crashed by 4163.86% to -$82.4 million in 2024, then crashed by 48.51% to -$122.4 million in 2025, then increased by 18.45% to -$99.8 million in 2026.
  • Business Quant data shows Cash from Financing Activities for HQY at -$99.8 million in Q1 2026, -$122.4 million in Q4 2025, and -$108.1 million in Q3 2025.